Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Artivion (AORT) Research & Development (2016 - 2026)

Artivion filings provide 16 years of Research & Development readings, the most recent being $9.1 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 23.2% to $9.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.0 million, a 8.92% increase, with the full-year FY2025 number at $31.0 million, up 8.92% from a year prior.
  • Research & Development hit $9.1 million in Q4 2025 for Artivion, up from $8.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $11.8 million in Q3 2022 to a low of $6.4 million in Q3 2023.
  • Median Research & Development over the past 5 years was $7.7 million (2021), compared with a mean of $8.1 million.
  • Biggest five-year swings in Research & Development: skyrocketed 73.28% in 2021 and later tumbled 45.58% in 2023.
  • Artivion's Research & Development stood at $9.5 million in 2021, then decreased by 12.22% to $8.3 million in 2022, then dropped by 7.94% to $7.6 million in 2023, then decreased by 3.15% to $7.4 million in 2024, then rose by 23.2% to $9.1 million in 2025.
  • The last three reported values for Research & Development were $9.1 million (Q4 2025), $8.1 million (Q3 2025), and $7.1 million (Q2 2025) per Business Quant data.